Media Summary: 44th Annual Meeting of the European Society for Blood and Marrow Transplantation ( Régis Peffault de Latour, MD, PhD, Saint-Louis Hospital, Paris, France, provides an overview of a talk at this year's virtual ... At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (

The Ebmt E Gvhd App Ebmt 2018 - Detailed Analysis & Overview

44th Annual Meeting of the European Society for Blood and Marrow Transplantation ( Régis Peffault de Latour, MD, PhD, Saint-Louis Hospital, Paris, France, provides an overview of a talk at this year's virtual ... At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation ( There is a vibrant worldwide community waiting for you at Mohamad Mohty discusses achievements over the last 4 years as President of Graft vs Host Disease is one of the biggest challenges clinicians face working in the field of HSCT, and little is known about the ...

Monia Marchetti, MD, Azienda Ospedaliera SS. Antonio The European Group for Blood and Marrow Transplantation Nurses Group ( Enjoy this free webinar covering all aspects of this potentially life-threatening post transplant complication: from pathophysiology ... Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, discusses the latest developments in

Photo Gallery

The EBMT e-GVHD App - EBMT 2018
Prof. Robert Zeiser | EBMT 2018 | The role of myeloid recipient-derived cells during GvHD
Nurses Educational Day - EBMT 2018
Prof. H. Joachim Deeg | EBMT 2018 | Treatment of steroid-refractory GvHD with alpha-1-antitrypsin
Dr. Frederic Baron | EBMT 2018 | The role of azacitidine in GvHD prevention
Overview of HSCT and GvHD at EBMT
Graft-versus-host disease (GvHD): Advances at EBMT 2016
Discover EBMT (formerly known as the European Society for Blood and Marrow Transplantation)
Mohamad Mohty, Outgoing EBMT President - EBMT 2018
EBMT's Open Access Nurses Textbook Released - EBMT 2018
Graft vs Host Disease at EBMT 2019
Madan Jagasia | EBMT 2019 | Six month follow-up results from the phase II REACH1 trial
View Detailed Profile
The EBMT e-GVHD App - EBMT 2018

The EBMT e-GVHD App - EBMT 2018

EBMT

Prof. Robert Zeiser | EBMT 2018 | The role of myeloid recipient-derived cells during GvHD

Prof. Robert Zeiser | EBMT 2018 | The role of myeloid recipient-derived cells during GvHD

44th Annual Meeting of the European Society for Blood and Marrow Transplantation (

Nurses Educational Day - EBMT 2018

Nurses Educational Day - EBMT 2018

EBMT

Prof. H. Joachim Deeg | EBMT 2018 | Treatment of steroid-refractory GvHD with alpha-1-antitrypsin

Prof. H. Joachim Deeg | EBMT 2018 | Treatment of steroid-refractory GvHD with alpha-1-antitrypsin

44th Annual Meeting of the European Society for Blood and Marrow Transplantation (

Dr. Frederic Baron | EBMT 2018 | The role of azacitidine in GvHD prevention

Dr. Frederic Baron | EBMT 2018 | The role of azacitidine in GvHD prevention

44th Annual Meeting of the European Society for Blood and Marrow Transplantation (

Overview of HSCT and GvHD at EBMT

Overview of HSCT and GvHD at EBMT

Régis Peffault de Latour, MD, PhD, Saint-Louis Hospital, Paris, France, provides an overview of a talk at this year's virtual ...

Graft-versus-host disease (GvHD): Advances at EBMT 2016

Graft-versus-host disease (GvHD): Advances at EBMT 2016

At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (

Discover EBMT (formerly known as the European Society for Blood and Marrow Transplantation)

Discover EBMT (formerly known as the European Society for Blood and Marrow Transplantation)

There is a vibrant worldwide community waiting for you at

Mohamad Mohty, Outgoing EBMT President - EBMT 2018

Mohamad Mohty, Outgoing EBMT President - EBMT 2018

Mohamad Mohty discusses achievements over the last 4 years as President of

EBMT's Open Access Nurses Textbook Released - EBMT 2018

EBMT's Open Access Nurses Textbook Released - EBMT 2018

The EBMT

Graft vs Host Disease at EBMT 2019

Graft vs Host Disease at EBMT 2019

Graft vs Host Disease is one of the biggest challenges clinicians face working in the field of HSCT, and little is known about the ...

Madan Jagasia | EBMT 2019 | Six month follow-up results from the phase II REACH1 trial

Madan Jagasia | EBMT 2019 | Six month follow-up results from the phase II REACH1 trial

45th Annual Meeting of

What is the EBMT and why should you join?

What is the EBMT and why should you join?

EBMT

Key EBMT guideline updates for the treatment and prophylaxis of GvHD

Key EBMT guideline updates for the treatment and prophylaxis of GvHD

Monia Marchetti, MD, Azienda Ospedaliera SS. Antonio

A rich digital resource for hemonc nurses: the EBMT NG website

A rich digital resource for hemonc nurses: the EBMT NG website

The European Group for Blood and Marrow Transplantation Nurses Group (

How to diagnose and treat VOD in 2021 | EBMT E-learning PDWP Webinar

How to diagnose and treat VOD in 2021 | EBMT E-learning PDWP Webinar

Enjoy this free webinar covering all aspects of this potentially life-threatening post transplant complication: from pathophysiology ...

Robert Zeiser | EBMT 2019 | Insights into GvHD pathophysiology and strategies to enhance GVL effects

Robert Zeiser | EBMT 2019 | Insights into GvHD pathophysiology and strategies to enhance GVL effects

Robert Zeiser |

What’s new in GVHD? Insights from the EBMT Annual Meeting 2026

What’s new in GVHD? Insights from the EBMT Annual Meeting 2026

Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, discusses the latest developments in